Clinical Trial Update: Efficacy Parecoxib and Ketorolac as Preemptive Analgesia in Spine Fusion [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy of preemptive parecoxib plus ketorolac for reducing postoperative pain in spine fusion patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Ketorolac (Ketorolac tromethamine)
• Parecoxib (parecoxib)

Snippet

Sponsor: Prince of Songkla University | Conditions: Postoperative Pain | Phase 4 | Status: COMPLETED